HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 2:606-641, 2003.
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

Program: Thursday, October 9, 2003

44. CSBMCB Merck-Frosst Lecture
08:00–08:40, Room 710
08:00 44.1
Large-scale Mapping of Genetics Networks with Ordered Arrays of Yeast Mutants
Charles Boone, University of Toronto, Toronto, ON, Canada

45. IUBMB/PABMB Lecture
08:45–09:25, Room 710
08:45 45.1
Control of Alternative Pre-mRNA Splicing of RNA Pol II Elongation: Faster Is Not Always Better
Alberto Kornblihtt, Universidad de Buenos Aires, Buenos Aires, Argentina

09:25 Coffee Break

46. Peter Dolphin Memorial Symposium Lipoproteins and Cell Interactions
This session was made possible through an unrestricted educational grant by the Department of Biochemistry, the Faculty of Medicine, and the Office of the Vice-President Research at Dalhousie University.
Chair: Roger McLeod, Dalhousie University, Halifax, Nova Scotia, Canada
Co-Chair: Catherine Lazier, Dalhousie University, Halifax, Nova Scotia, Canada
09:35–11:45, Room 514ABC
09:35 46.1
Amino Acid Sequences Within the ß1 Domain of Human Apolipoprotein B Mediate Rapid Intracellular Degradation
Roger McLoed, Dalhousie University, Halifax, Nova Scotia, Canada
46.2
CETP: A Key Therapeutic Target in Atherogenic Dyslipidemia
John Chapman, Hôpital de la Pitié, Paris, France
46.3
Macrophage Foam Cell Formation in Atherosclerosis: Regulation by the Nuclear Hormone Receptors, PPAR, LXR and RXR
Murray Huff, University of Western Ontario, London, ON, Canada
46.4
The ApoE-Nitric Oxide Pathway: Anti-platelet and Anti-inflammatory
Jim Owen, Royal Free & University College Medical School, London, United Kingdom

47. Concurrent Session 14
Small GTPases in Cell Migration
Chair: Anne Ridley, Ludwig Institute of Cancer Research, London, United Kingdom
Co-Chair: Alan Mak, Canada
09:35–11:05, Room 518ABC
09:35 47.1
Rho GTPases: Signaling in Cell Adhesion and Migration
Anne Ridley, Ludwig Institute of Cancer Research, London, United Kingdom
47.2
Rho GTPases: Signaling and Transcriptional Activation in Cell Transformation and Metastasis
Juan-Carlos Lacal, Instituto de Investigaciones Biomédicas, Madrid, Spain
47.3
The Rho Family on the Move
Louis Lim, Institute of Molecular and Cell Biology, Singapore

48. Concurrent Session 15
Structure and Dynamics of Protein Folding and Misfolding
Chair: Valerie Daggett, University of Washington, Seattle, WA, United States
Co-Chair: Vettai Ananthanarayanan, McMaster University, Hamilton, ON, Canada
09:35–11:05, Room 519AB
09:35 48.1
NMR Approaches for the Study of Protein Dynamics and Function
Oscar Millett, University of Toronto, Toronto, Ontario, Canada
48.2
Protein Misfolding and Human Amyloid Diseases
S.T. Ferreira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
48.3
Protein Folding/Unfolding at Atomic Resolution
Valerie Daggett, University of Washington, Seattle, WA, United States

49. Concurrent Session 16
Rational Drug Design
Chair: Francois Franceschi, Rib-X Pharmaceuticals, New Haven, Connecticut, United States
Co-Chair: Lynne Howell, Hospital For Sick Children, Toronto, ON, Canada
09:35–11:05, Room 524ABC
09:35 49.1
Ribosome as a Drug Target: Defining Potential Sites of Antibiotic Action
Alexander Mankin, University of Illinois, Center for Pharmaceutical Biotechnology, Chicago, IL, United States
49.2
Structure Based Drug Design of Ribosomal Antibiotics
Francois Franceschi, Rib-X Pharmaceuticals Inc., New Haven, Connecticut, United States
49.3
Old and New Drugs Against Xanthine Dehydrogenase/Oxidase
Emil Pai, University of Toronto, Toronto, ON, Canada

50. Concurrent Session 17
Molecular Motors
Chair: Christine Cremo, University of Nevada-Reno, Reno, NV, United States
Co-Chair: David Litchfield, Canada
09:35–11:05, Room 520CF
09:35 50.1
Regulation of Smooth and Nonmuscle Myosins II
Christine Cremo, University of Nevada-Reno, Reno, NV, United States
50.2
Relating Structure to Mechanism in Helicases
Dale Wigley, Cancer Research UK Clase Hall Laboratories, Potters Bar, United Kingdom
50.3
Subunit Rotation of ATP Synthase in Membranes: A Biological Nanomachine Synthesizing Energy Currency
Atsuko Iwamoto-Kihara, Nagahama Institute for Biosciences, Japan

51. Concurrent Session 18
Signaling Molecules in Development
Chair: Sarah Childs, University of Calgary, Faculty of Medicine, Calgary, AB, Canada
Co-Chair: Ilona Skerjanc, University of Western Ontario, London, ON, Canada
09:35–11:05, Room 520BE
09:35 51.1
Transfer of Asymetric Signals During Left-Right Patterning
Hiroshi Hamada, Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan
51.2
Guidance of Angiogenesis in Zebrafish
Sarah Childs, University of Calgary, Faculty of Medicine, Calgary, AB, Canada
51.3
From Embryo to Adult: The Kidney as a Model System
Andy McMahon, Harvard University, Cambridge, MA, United States

52. Concurrent Session 19
Global Analysis of Annotation, Structure, and Function
This session was made possible by an unrestricted educational grant by the Institute of Genetics/CIHR.
Chair: Cheryl Arrowsmith, University of Toronto, Toronto, ON, Canada
09:35–11:05, Room 520AD
09:35 52.1
Structural Proteomics
Cheryl Arrowsmith, University of Toronto, Toronto, ON, Canada
52.2
The Comparison of Mouse and Human Genomes by ENSEMBL
Eduardo Eyras, The Welcome Trust Genome Campus, Cambridge, United Kingdom
52.3
Global Analysis of Biochemical Activities Using Protein Chips
Michael Snyder, Yale University, New Haven, CT, United States

53. Concurrent Session 20
DNA Repair
This session was made possible through an unrestricted educational grant by the Institute of Genetics/CIHR.
Chair: Susan Lees-Miller, University of Calgary, Calgary, AB, Canada
Co-Chair: Frances Sharom, University of Guelph, Guelph, ON, Canada
11:15–12:45, Room 520BE
11:15 53.1
Regulation of Non-homologous End Joining by Phosphorylation
Susan Lees-Miller, University of Calgary, Calgary, AB, Canada
53.2
Repair of Damaged DNA in Vertebrates
Shunichi Takeda, Kyoto University, Kyoto, Japan
53.3
Defective DNA Damage Response and Cancer Risk
Kum Kum Khanna, The Queensland Institute of Medical Research, Brisbane, Australia

54. Concurrent Session 21
Proteins in Pathology and Therapy
Chair: William J. Lennarz, State University of New York at Stony Brook, Stony Brook, NY, United States
Co-Chair: Bruce Allen, Montreal Heart Institute, Montréal, QC, Canada
11:15–12:45, Room 520AD
11:15 54.1
Ribonucleases as Antitumor Agents
Renata Piccoli, Università di Napoli Federico II, Naples, Italy
54.2
Hijacking of Mismatch Repair to Cause DNA Expansion in Human Diseases
Cynthia McMurray, Mayo Clinic Rochester, Rochester, MN, United States
54.3
The Proprotein Convertases in Health and Disease
Nabil G. Seidah, Clinical Research Institute of Montréal, Montréal, QC, Canada

55. Concurrent Session 22
Regulation of Signal Transduction by Lipid Mediators
Chair: David Brindley, University of Alberta, Edmonton, AB, Canada
Co-Chair: Elena Posse De Chaves, University Of Alberta, Edmonton, AB, Canada
11:15–12:45, Room 524ABC
11:15 55.1
Lipid Phosphate Phosphatase 1 (LPP1) Regulates Lysophosphatidic Acid Signaling in Platelets
Andrew Morris, University of North Carolina, Chapel Hill, NC, United States
55.2
Computational Approaches to Phospholipid Growth Factor Receptor Structure and Function
Gabor Tigyi, University of Tennessee Health Sciences Center, Memphis, TN, United States
55.3
Cell Signaling by Lipid Phosphates and Their Phosphatases
David Brindley, University of Alberta, Edmonton, AB, Canada

56. Oral Session 11
Organelle Proteomics
Chair: Peter S. McPherson, Montreal Neurological Institute, Montréal, QC, Canada
11:15–12:45, Room 518ABC
11:15 56.1
Quantitative Protein Profilining in Heart Mitochondria from Diabetic Rats Using Stable Isotope Labeling with Deuterated Acrylamide
Illarion Turko, University of Texas Medical School, Houston, TX, United States
11:30 56.2
Comprehensive Profiling of the Surface Membrane Proteome of Cancer Cells Uncovers a Substantial Overlap with the Exosomal Compartment
David Misek, University of Michigan, Ann Arbor, MI, United States
11:45 56.3
ER-mediated Phagocytosis: Phagosomes Are Competent Organelles for Antigen Cross Presentation
Mathieu Houde, Université de Montréal, Montréal, QC, Canada
12:00 56.4
Proteomics Analysis of Brain Clathrin-Coated Vesicles
François Blondeau, McGill University, Montréal, QC, Canada
12:15 56.5
Lysosomal Membrane Proteomics: Elucidating Novel Functions of the Lysosome
Rick Bagshaw, The Hospital for Sick Children, Toronto, ON, Canada
12:30 56.6
Organelle Footprinting Using GFP-tagging of Novel Proteins
Jeremy Simpson, EMBL, Heidelberg, Germany

57. Oral Session 12
Medical Proteomics—Genetic Diseases
Chair: Charles Scriver, McGill University, Montréal, QC, Canada
11:15–12:45, Room 519AB
11:15 57.1
A Third Human Carnitine/Organic Cation Transporter (OCTN3) as a Candidate for the 5q31 Crohn’s Disease Locus (IBD5)
Anne-Marie Lamhonwah, Hospital for Sick Children, Toronto, ON, Canada
11:33 57.2
Complex Expression Pattern of the Barth Syndrome Gene Tafazzin in Murine and Human Tissues
Biao Lu, University of Manitoba, Winnipeg, MB, Canada
11:51 57.3
The Characterization of CFTR-associated Proteins by Mass Spectrometry
William Thelin, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
12:09 57.4
Analysis of Differentially Displayed Proteins in HeLa Cells Expressing CFTR and 508 CFTR
Noélie Davezac, INSERM U467, Paris, France
12:27 57.5
Pharmacological Enhancement of Beta-hexosaminidase A Activity in Fibroblasts from an Adult Tay-Sach Patient
Don Mahuran, Hospital for Sick Children, Toronto, ON, Canada

58. Oral Session 13
Proteomics & Biotechnology
Chair: Daniel Chelsky, Caprion Pharmaceuticals, Montréal, QC, Canada
11:15–14:45, Room 520CF
11:15 58.1
Differential Expression Analysis of Proteins in Complex Human Samples by Stable Isotope Labeling: How and Why?
Peter Juhasz, Applied Biosystems, Framingham, MA, United States
11:37 58.2
New Surface Enhanced Neat Desorption SELDI Protein Biochip Arrays for Evaluating the Low Molecular Weight Proteome of Nasopharyngeal Swab Samples of SARS Patients
Scot Weinberger, Ciphergen Biosystems, Inc., Fremont, United States

11:59 58.3
Global Proteome Analysis of Human Serum
Thomas Conrads, SAIC-Frederick Inc., Frederick, MD, United States
12:21 58.4
Quantitative Proteomics for Tumor Immunotherapy and Biomarker Discovery
Daniel Chelsky, Caprion Pharmaceuticals, Montréal, QC, Canada
12:45

Lunch Break, Poster Viewing, Exhibits, Industry-Sponsored Sessions: Amersham, Applied Biosystems

59. Concurrent Session 23
Biology of Aging (Molecular Gerontology)
Chair: Brian F. C. Clark, Aarhus University, Aarhus, Denmark
Co-Chair: Arun Seth, Canada
14:45–17:00, Room 520AD
14:45 59.1
Slowing Down Aging from Within: Applying Hormesis in Biogerontology
Suresh Rattan, University of Aarhus, Denmark
59.2
Proteomic, Transcriptomic, Signal Transduction and Functional Studies of Stress-induced Premature Senescence (SIPS) and Potential Role of SIPS in Human Aging
Olivier Toussaint, University of Namur (FUNDP), Namur, Belgium
59.3
Longevity and Survival Factors Implicated in Human Senescence and Aging
Efstathios S. Gonos, National Hellenic Research Foundation, Athens, Greece
59.4
Damaged Protein Repair and Degradation During Aging
Bertrand Friguet, Universite Denis Diderot, Paris, France

60. Concurrent Session 24
Educational Session: Data Techniques
Chair: Raymonde Joubert-Caron, University Paris 13, Ufr Smbh, Bobigny Cedex, France
14:45–18:00, Room 514ABC
14:45 60.1
Data Mining
Carsten Petersson, Lund University, Lund, Sweden
60.2
Systems Biology Data
Trey Ideker, University of California at San Diego, La Jolla, CA, United States
60.3
Integrating Data in Oncology
David Beer, University of Michigan, Ann Arbor, MI, United States
60.4
Data Analysis to Biology
Sorin Draghici, Wayne State University, Detroit, MI, United States

61. Oral Session 14
HUPO Proteomics Standards Initiative
Co-Chair: Weimin Zhu, Embl-Ebi, Cambridge, United Kingdom
Co-Chair: Rolf Apweiler, Embl-Ebi, Cambridge, United Kingdom
14:45–16:15, Room 524ABC
14:45 61.1
The HUPO Proteomics Standards Initiative
Rolf Apweiler, Embl-Ebi, Cambridge, United Kingdom
14:56 61.2
The HUPO Proteomics Standard Initiative—Mass Spectrometry Standardization Efforts
Weimin Zhu, Embl-Ebi, Cambridge, United Kingdom
15:07 61.3
Analytical Information Management Standards and Proteomics
Randall Julian, Lilly Research Laboratories, IN, United States
15:18 61.4
An XML Based Proteomics-oriented Markup Language to Accelerate Collaboration Among Researchers: HUP-ML
Akihisa Kenmochi, Nec Corporation, Tsukuba, Japan
15:29 61.5
Data Standards for Two-dimensional Gel Electrophoresis
Veerasamy Ravichandran, National Institute of Standards and Technology, Gaithersburg, MD, United States
15:40 61.6
The HUPO PSI Molecular Interaction Format—A Standard Representation of Protein Interaction Data
Henning Hermjakob, Embl-Ebi, Cambridge, United Kingdom
15:51 61.7
CEBS Object Model for Systems Biology, CEBS MAGE Sys BioOM
Sandhya Xirasagar, Science Applications International Corporation, Germantown, MD, United States
16:02 61.8
A Systematic Approach to Modelling, Capturing and Disseminating Proteomics Experimental Data
Chris Taylor, University of Manchester, Manchester, UK

62. Oral Session 15
Medical Proteomics—Heart & Stroke
Chair: Peipei Ping, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States
14:45–16:15, Room 520CF
14:45 62.1
Proteomic Analysis of Myocardial Mitochondrial Protein Expression in Rats with Heart Failure
Pengyuan Yang, Fudan University, Shanghai, P.R. China
15:00 62.2
Controlled Delivery of Vascular Endothelial Growth Factor for Therapeutic Angiogenesis
Frank Gu, Queen’s University, Kingston, ON, Canada
15:15 62.3
Improved Protemomics Analysis for Laboratory Medicine
Jean-Charles Sanchez, Geneva University Hospital, Geneva, Switzerland
15:30 62.4
Vasoconstriction Triggered by Transactivation of Growth
Carlos Fernandez-Patron, University of Alberta, Edmonton, AB, Canada
15:45 62.5
Homocyteine Important Risk Factor in the Cardiovascular Disease
Suleyman Aydin, Firat University, Medical School, Elazig, Turkey
16:00 62.6
The Relationship Between Oxidative Stress and the Onset of Coronary Artery Disease (CAD)
Parvin Pasalar, Tehran University of Medical Sciences, Tehran, Iran

63. Oral Session 16
Nanotechnology
Chair: Yoshinobu Baba, The University of Tokushima, Shomachi, Japan
14:45–16:15, Room 519AB
14:45 63.1
Nano-Bio Device for Proteomics
Yoshinobu Baba, The University of Tokushima, Shomachi, Japan
15:15 63.2
Automated Chip-based Nanoelectrospray Mass Spectrometry for the Quantitative Determination of Noncovalent Protein-Ligand Binding Interactions
Sheng Zhang, Advion Biosciences, Ithaca, NY, United States
15:35 63.3
Novel Nib-like Nano-ESI Emitter Tips for Reliable and Automated ESI-MS
Steve Arscott, Université des Sciences et Technologies, Villeneuve D’ascq, France
15:55 63.4
Combination of the Optical Biosensor with Mass Spectrometry
Alexander Archakov, Institute of Biomedical Chemistry Rams, Moscow, Russia

64. Oral Session 17
Technical Innovations—2D Gels and Other Gel Systems
Chair: David W. Speicher, The Wistar Institute, Philadelphia, PA, United States
14:45–16:15, Room 520BE
14:45 64.1
2-D Electrophoresis with Immobilized pH Gradients: Enhanced Coverage of the Proteome
Angelika Gorg, Technical University of Munich, Freising-Weihenstephan, Germany
15:05 64.2
Comprehensive Analysis of Complex Proteomes Using Zoom IEF Prefraction and High Throughput Narrow Range 2-D Gels
David W. Speicher, The Wistar Institute, Philadelphia, PA, United States
15:15 64.3
A New Ruthenium Complex for 2D Gel Electrophoresis Revelation
Caroline Tokarski, Université des Sciences et Technologies, Villeneuve D’ascq, France
15:27 64.4
High Throughput 2D Protein Expression Mapping Using the Digital Proteomechip
Russell Garlick, Protein Forest Inc., Cambridge, MA, United States
15:39 64.5
Rapid Fractionation of Complex Protein Extracts with Centrifugal Membrane Adsorber Units Improves Detection of Proteins in 2D PAGE
Robert Zeidler, Vivascience AG, Hannover, Germany
15:51 64.6
Three-dimensional Electrophoresis: Analytical Access to Low Abundant Proteins
Christoph Eckerskorn, Tecan Munich GmbH, Kirchheim, Germany
16:03 64.7
Preparative Two-dimensional Liquid Based Proteomic Separations Using Free-flow Electrophoresis and Reversed-phase High Performance Liquid Chromatography
Richard Simpson, Ludwig Institute for Cancer Research, Parkville, Australia

16:15
Coffee Break

65. Oral Session 18
Medical Proteomics—Obesity & Diabetes
Chair: Barry Posner, McGill University, Montréal, QC, Canada
16:30–18:00, Room 520BE
16:30 65.1
Proteomic Characterization of Adipocyspin, a Novel Fat-derived Secretory Protein Involved in Modulating Adipocyte Differentiation
Aimin Xu, The University of Hong Kong, Hong Kong, P.R. China
16:48 65.2
Proteomic and Functional Analysis of the Fat-derived Anti-diabetic Hormone Adiponectin Purified from Fetal Bovine Serum
Yu Wang, The University of Auckland, Auckland, New Zealand
17:06 65.3
Differentially Expressed Protein Profiles in the Pancreas of TGZ-treated ZDF Rats, Obese and Type 2 Diabetic Animal Model
Je Kyung Seong, Seoul National University, Seoul, South Korea
17:24 65.4
Proteomic Analysis of Pancreas Regeneration-related Proteins in Pancrectomized Rats
Je Kyung Seong, Seoul National University, Seoul, South Korea
17:42 65.5
Proteomics in an Animal Model of Insulin Resistance and Metabolic Dyslipidemia
Jean-Paul Morand, The Hospital for Sick Children, Toronto, ON, Canada

66. Concurrent Session 25
Looking Ahead: A Vision for the Future of Proteomics
16:30–18:00, Room 519AB
16:30 66.1
Allen Spiegel, National Institute of Health, Baltimore, MD, United States

67. Concurrent Session 26
PSI Meeting
Chair: Henning Hermjakob, Embl-Ebi, Cambridge, United Kingdom
16:30–18:00, Room 515ABC

68. Oral Session 19
Medical Proteomics—Cancer
Chair: Daniel Chan, Johns Hopkins Medical Institutions, Baltimore, MD, United States
16:30–18:00, Room 520CF
16:30 68.1
Cancer Proteomics: From Discovery to Diagnostics
Daniel Chan, Johns Hopkins Medical Institutions, Baltimore, MD, United States
16:45 68.2
Proteomic Profiling of Suspicious Lung Nodules: Serum Based Differentiation of Benign States from Non Small Cell Lung Cancer
C. Denise Ching, Duke University, Durham, NC, United States
17:00 68.3
Discovery and Identification of Protein Markers in Endometrial Carcinoma
K. W. Michael Siu, York University, Toronto, ON, Canada
17:15 68.4
Proteome Analysis on HCV-infected Hepatocellular Carcinoma by 2-DE and MALDI-TOF/MS
Kazuyuki Nakamura, Yamaguchi University School of Medicine, Ube, Japan
17:30 68.5
Proteomic Analysis of Pancreatic Cancer Using 2-DE Coupled Antibody Microarray
Xiaohang Zhao, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, P.R. China
17:45 68.6
Serum Proteomic Analysis of Response Outcome in FAP/Celecoxib Clinical Trial
Iqbal U. Ali, National Cancer Institute, Bethesda, MD, United States

69. Oral Session 20
Proteomes of Non Human Model
Chair: Jérôme Garin, CEA/Grenoble, Grenoble, France
16:30–18:00, Room 518ABC
16:30 69.1
Proteins Induced by Hypoxic Treatment of Rat Brain Capillary Endothelial Cells
Reiner F. Haseloff, Research Institute of Molecular Pharmacology, Berlin, Germany
16:48 69.2
Definition of the Tissue and Organelle Specific Mouse Proteome
Thomas Kislinger, University of Toronto, Toronto, ON, Canada
17:06 69.3
Proteome Dynamics During Myoblast Cell Proliferation and Differentiation
Andrew Emili, University of Toronto, Toronto, ON, Canada
17:24 69.4
Discovery and Identification of Rat Liver Cirrhosis Biomarker Candidates Using Protein Profiling, Bioinformatics, MALDI-TOF MS, and MALDI-TOF/TOF MS
Hon-chiu Eastwood Leung, Genome Institute Of Singapore, Singapore
17:42 69.5
Assessment of a Mouse Model for a Proteomic Analysis of Human GVHD (Graft Versus Host Disease)
Jérôme Garin, CEA/Grenoble, Grenoble, France

70. Oral Session 21
HUPO Initiative—Brain
Chair: Helmut E. Meyer, University of Bochum, Bochum, Germany
16:30–18:00, Room 524ABC
16:30 70.1
The HUPO Human Brain Proteome Project
Helmut E. Meyer, University of Bochum, Bochum, Germany
16:55 70.2
Brain Proteome: A Comparative Study of Different Mouse Models for Neurodegenerative Diseases
Joachim Klose, Institute for Human Genetics, University Clinic Charité, Berlin, Germany
17:20 70.3
Multi-dimensional Separation of Mouse Brain Proteins
Katrin Marcus, Ruhr University of Bochum, Bochum, Germany
17:40 70.4
The Rat Hippocampal Proteome
Freya Vercauteren, Douglas Hospital Research Center, Verdun, QC, Canada

71. Poster Session 19
Informatics—Bioinformatics
71.1
Organizing the Data Generated by the Local Proteomic Project
Andrey Lisitsa, V. N. Orekhovich Institute of Biomedical Chemistry RAMS, Moscow, Russia
71.2
BGI_MS2Cluster: An Algorithm for Clustering LC/MS/MS Spectra
Jiandong Sun, Beijing Genomics Institute, Beijing, P.R. China
71.3
Database for Protein Interactions Involved in Poly(ADP-Ribose) Metabolism
Arnaud Droit, Chul Research Center, Sainte-Foy, QC, Canada
71.4
SIMS: A New Database Search Algorithm for Identifying Protein Post-translational Modifications and Sequence Substitutions from Peptide MS/MS Spectra
Alexandre Erassov, University of Toronto, Toronto, ON, Canada
71.5
Novel Algorithms for Terminal Sequence Libraries’ Construction
Tao Chen, Cidmax Corporation, London, ON, Canada
71.6
Bioinformatics in the Identification of Glycosidase Genes in the Chlamydia Genome
Sanjiv Rughooputh, University of Westminster, London, United Kingdom
71.7
Prediction of Post-translational GPI Anchor Modification of Protein by Machine Learning
Guylaine Poisson, Université du Québec a Montréal, Montréal, QC, Canada
71.8
PSI Based Basic Information Management Platform and Protein Identification Using Mass Spectrometric Data by Profinder Software for Proteomics Research
Li Yixue, Shanghai Institutes for Biological Sciences, CAS, Shanghai, P.R. China
71.9
Uniprot—A Comprehensive Knowledgebase of Protein Sequence and Function
Sandra Orchard, Embl-Ebi, Hinxton, Cambridge, United Kingdom
71.10
Proteome Analysis at the EBI
Manuela Pruess, Embl-Ebi, Hinxton, Cambridge, United Kingdom
71.11
Sequence Based Prediction of Endoplasmic Reticulum Resident Proteins Using Machine Learning Approaches
Michelle Scott, McGill University, Montréal, QC, Canada
71.12
Study on Transcriptome of Human Fetal Liver Aged 22 wk of Gestation (HFL22W)
Donggen Wang, Beijing Institute of Radiation Medicine, Beijing, P.R. China
71.13
Sequence Analysis of the BTB Domain, a Widespread Eukaryotic Protein-Protein Interaction Module
Peter J. Stogios, University of Toronto, Toronto, ON, Canada
71.14
An Informatic System for Automated Proteomic Data Collection and Analysis
René Paradis, Centre de Recherche du CHUL, Université Laval, St-Foy, QC, Canada
71.15
AMASS, a Bioinformatic Tool for Validation of SEQUEST Search Results by Automatic Screening of Its Ion Maps
Youhe Gao, Proteomics Research Center, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, P.R. China
71.16
CHOMPER: A Bioinformatic Tool for Rapid Visualisation and Validation of SEQUEST and Mascot MS/MS Search Results
James Sorrell Eddes, Ludwig Institute for Cancer Research & The Walter and Eliza Hall, Institute of Medical Research, Parkville, Victoria, Australia
71.17
Relative Entropy: A More Accurate Measurement Compared to the Propensity Calculation for Amino Acids in Different Helical Positions
Bahram Goliaei, Institute of Biochemistry and Biophysics, Tehran, Iran
71.18
Protein-Protein Interactions in Human Fetal Liver Aged 22 Weeks (HFL22W)
Zhu Yunping, Beijing Institute of Radiation Medicine, Beijing, P.R. China
71.19
Data Format for Computational Analysis of Intermetabolite Atom-level Connectivity in Metabolic Networks
Jun Ohta, Okayama University, Okayama, Japan
71.20
Sliding Window Approach to Filtering Contaminants from Mass Spectrometry Spectra
Barry Kesner, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
71.21
Evaluation of Noise in DNA Fingerprint Images
Akbar Akbari, University of Oslo, Oslo, Norway
71.22
Development of a Robust Software-based Method for Noise Filtering in Time-of-Flight Mass Spectra
Kossi Lekpor, McGill University, Montréal, QC, Canada
71.23
MS/MS Duty Cycle Analysis for Quality and Quantity of Peptide Spectra
Brian Carrillo, McGill University and the Montréal Proteomics Network, Montréal, QC, Canada
71.24
An Effective Residue-Residue Contact Potential for Protein Structure Prediction
Brendan McConkey, University of Waterloo, Waterloo, ON, Canada
71.25
Repeatability of Peptide Counting Using Intensity Surface Analysis
Brian Carrillo, McGill University and the Montréal Proteomics Network, Montréal, QC, Canada
71.26
The Rancourt EST Database and Its Usage in a Multidisplinary Research Environment: Preliminary Examination of a Putative Transcriptional Regulator Analyzed by RED
Stephanie Minnema, University of Calgary, Calgary, AB, Canada
71.27
TOMAS: Toolbox for Mass Spectrometry Data Analysis
Frank Morales, Montréal Proteomics Network, McGill University, Montreal, QC, Canada
71.28
A Correlation Algorithm for MS/MS Peptide Spectra Combined with a Model for Probability of Protein Misidentification Optimizes the Identification of Peptides and Proteins
Colette Rudd, Thermo Electron, San Jose, CA, United States
71.29
AnaBench: A Web/CORBA-based Workbench for Biomolecular Sequence Analysis and Annotation
Gertraud Burger, Université de Montréal, Montréal, QC, Canada
71.30
Hcc-Rdb (Hepatocellular Carcinoma Reference Database)
Lee Lang-Ho, Yonsei Proteome Research Center, Seoul, South Korea
71.31
Information System for High-throughput Proteomics: CellMapBase
Zsuzsanna Bencsath-Makkai, Montréal Proteomics Network, Montréal, QC, Canada

72. Poster Session 20
Proteomes of Non Human Model
72.1
Synthesis of Paucimannose N-Glycans by Caenorhabditis elegans Requires UDP-GlcNAc: Alpha-3-D-Mannoside Beta-1,2-N-Acetylglucosaminyltransferase I, Alpha-3,6-Mannosidase II and a Specific Membrane-bound Beta-N-Acetylglucosaminidase
Harry Schachter, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada
72.2
Proteomic Analysis of the Protein Mixture Secreted by 3T3-L1 Preadipocytes and Adipocytes
Hu Zhou, Research Center Proteome Analysis, Chinese Academy of Sciences, Shanghai, China
72.3
Application of Two-dimensional Electrophoretic Techniques for Separation of Complex Protein Mixtures from Rat Liver and Rat Brain Endothelial Cells
Kerstin Mikoteit, Research Institute for Molecular Pharmacology, Berlin, Germany
72.4
Characterization of the Post-translational Modifications of Rat Bone Osteopontin
Gilles Lajoie, University of Western Ontario, London, ON, Canada
72.5
2-Dimensional Gel Electrophoresis Proteomic Database of Rabbit Ventricular Myocytes
Steven Elliott, Queen’s University, Kingston, ON, Canada
72.6
Proteomic Analysis and Comparison of Adult Rat Schwann Cells and Fetal Rat Olfactory Ensheathing Cells
Ali Jahed, Queen’s University, Kingston, ON, Canada

73. Poster Session 21
Medical Proteomics—Cancer
73.1
Development of Proteomic Patterns for Detecting Lung Cancer
Dacheng He, Beijing Normal University, Beijing, P.R. China
73.2
Identification of Biomarkers for Ovarian Cancer Using SELDI-TOF-MS Sax2 ProteinChips: Potential Use in Diagnosis and Prognosis
Katherine Kozak, University of California, Los Angeles, CA, United States
73.3
Proteomic Analysis of Hedychium coronarium Induced Protein Alterations in Hepatocellular Carcinoma Cells
Chantragan Srisomsap, Chulabhorn Research Institute, Bangkok, Thailand
73.4
The Relationship Between E-cadherin, Alpha-catenin, Gleason Score and Prostate Specific Antigen in Human Prostate Tissue
Shirley Motaung-Mashigo, Technikon Pretoria, Pretoria, South Africa
73.5
Proteomic Study of Liver Cancer Cells Using Fluorescence Two-dimensional Difference Gel Electrophoresis (2D-DIGE) with High-sensitive Fluorescent Dyes Combined with Statistical Methods
Kazuyasu Fujii, National Cancer Center Research Institute, Chuo-Ku, Japan
73.6
Metastasis-associated Proteomic Signature of Pancreatic Cancer Cells—Study by Fluorescence Two-dimensional Difference Gel Electrophoresis (2D-DIGE) Combined with Statistical Methods
Tadashi Kondo, National Cancer Center Research Institute, Chuo-Ku, Japan
73.7
Proteomic Signature of Alpha-fetoprotein (AFP) Producing Human Hepatocellular Carcinoma Cells
Hideki Yokoo, National Cancer Center Research Institute, Chuo-Ku, Japan
73.8
A Novel Autoantigen in Patients with Nevrological Paraneoplastic Syndromes
Anette Susanne Boe, Haukeland University Hospital, Bergen, Norway
73.9
Comparative Expression Profiles of Androgen-responsive Genes in Malignant and Non-malignant Ovarian Epithelial Cells Using Microarray Technology
Afsaneh Motamed-Khorasani, Samuel Lunenfeld Research Institute, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada
73.10
Serum Peptide Signatures of Solid Tumor Cancers
Paul Tempst, Memorial Sloan Kettering Cancer Center, New York, NY, United States
73.11
Proteomic Classification of Lung Cancer Cell Lines and Tumors Corresponding to Histological Background and Clinical Staging
Seike Masahiro, National Cancer Center Research Institute, Tokyo, Japan
73.12
The Expression Level of Matrix Metalloproteinases [2,9] and Their Inhibitors in Breast Cancer
Fawzia Khalil, Ain Shams University, Cairo, Egypt
73.13
Proteomic Analysis of Hepatocellular Carcinoma Metastasis Associated Proteins and Its Clinical Significance
Shi-Jian Ding, Institute of Biochemistry and Cell Biology, CAS, Shanghai Institutes for Biological Sciences, Shanghai, P.R. China
73.14
Proteomics of Breast Cancer: From Differential to Functional Analyses
Hubert Hondermarck, University of Lille, Villeneuve D’ascq, France
73.15
High Molecular Mass Proteome of Prostate Cancer Is Rich in Proteins Belonging to Gene/Protein Expression Group
Tadakazu Maeda, Kitasato University School of Science, Sagamihara-shi, Kanagawa, Japan
73.16
A New Highly Metastasis Breast Cancer Cell Line (LM-MCF-7) Identified from SCID Mice Injected MCF-7 Cells and Its Application
Lihong Ye, College of Life Sciences, Nankai University, Tianjin, P.R. China
73.17
Investigating the Resistance to Tamoxifen in a Human Breast Malignant Tumor Line: A Proteomic Approach
Vladimir Besada, Centro de Ingenieria Genetica y Biotecnologia, La Habana, Cuba
73.18
Modulation of Telomerase Gene Expression by Zinc in Bladder Cancer Patients
Nosratollah Zarghami, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
73.19
Study of Serum Levels of Stem Cell Factor (SCF) in Patients with Bladder Cancer
Nosratollah Zarghami, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
73.20
Identification of Tumor Markers and Tumor-associated Antigens in Human Renal Cell Carcinoma (RCC) Using Proteome-based Methods
Barbara Seliger, The Johannes Gutenberg University, Mainz, Germany
73.21
Verotoxin Sensitivity of ECV304 Cells In Vitro and In Vivo in a Xenograft Tumour Model
Hannah Heath-Engel, The Hospital for Sick Children, Toronto, ON, Canada
73.22
Proteomic Patterns in Mass Spectra of Seminal Fluid Discriminate Prostate Cancer from Benign Disease
Terence Walsh, Queensland University of Technology, Brisbane, Queensland, Australia
73.23
NMR Studies of the Relationship Between the Changes of Membrane Lipids and the Cisplatin-resistance of A549/DDP Cells
Zhenhua Huang, Institute of Biophysics, Chinese Academy of Science, Beijing, P.R. China
73.24
Proteomic Study on Nonmuscle Tropomyosin Isoforms in Esophugeal Cancer Tissues
Lishun Wang, Beijing Genomics Institute, Chinese Academy of Medicine, Beijing, P.R. China and Beijing Proteomics Institute, Beijing, China
73.25
Differential Proteomic Analysis of Human Gastric Carcinomas
Na Li, Beijing Genomics Institute, Chinese Academy of Medicine, Beijing, P.R. China and Beijing Proteomics Institute, Beijing, China
73.26
Optimizing Micro Range 2-D Gels for Comprehensive Cancer Cell Proteome Analysis After Microscale Solution IEF Sample Prefractionation
Kibeom Lee, The Wistar Institute, Philadelphia, PA, United States
73.27
Ovarian Cancer Biomarker Amplification by Serum Carrier Protein Binding
Mark Lowenthal, National Institutes of Health, Bethesda, MD, United States
73.28
Use of Reverse Phase Protein Microarrays Coupled with Laser Capture Microdissection for Proteomic Evaluation of Human Breast Cancer Signal Pathway Profiling
Valerie Calvert, FDA-NCl Clinical Proteomics Program, Bethesda, MD, United States
73.29
Multiparametric Signal Transduction Profiling of Human Ovarian Cancer Using Reverse-phase Protein Microarrays
Julia Wulfkuhle, National Institutes of Health, Bethesda, MD, United States
73.30
Signal Pathway Profiling of Prostate Cancer Using Reverse Phase Protein Arrays
Robert Grubb, National Cancer Institute, Bethesda, MD, United States
73.31
Proteomic Analysis of Hepatocellular Carcinoma-related Proteins in HBX Tg Mouse
Je Kyung Seong, Seoul National University, Seoul, South Korea
73.32
Proteomic Analysis and Functional Characterization of Lung Cancer
Kang-Sik Park, Yonsei Proteome Research Center, Seoul, South Korea
73.33
Composite Analyses of Metabolic Profiles of Proteins That Are Differentially Expressed in Hepatocellular Carcinoma
Kang-Sik Park, Yonsei Proteome Research Center, Seoul, South Korea
73.34
Proteotope Analysis of Microdissected Proteomes
André Schrattenholz, ProteoSys AG, Mainz, Germany

74. Poster Session 22
HUPO Initiative—Brain
74.1
The Effect of Delta Sleep-inducing Peptide on the Interleukins Content in the Tissues of White Mice at Stress
Magda Melkonyan, Yerevan State Medical University After Mkhitar Heratsi, Yerevan, Armenia
74.2
The Comparison of Changes of Brain Cells Nuclei and Chromatin in Unilateral Gangliosympathectomy
Gagik Hoveyan, Yerevan State Medical University After Mkhitar Heratsi, Yerevan, Armenia

75. Poster Session 23
Pharmaceutical Proteomics
75.1
Evaluation of NAG-Thiazoline in Mice: A Chemical Chaperone for the Treatment of Adult Tay-Sachs and Sandhoff Diseases
Brigitte Rigat, The Hospital for Sick Children, Toronto, ON, Canada
75.3
Cytotoxic, Antimicrobial and Antimutagenic Properties of the Bioactive Components of Coriaria intermedia matsum. (Buakat) Leaves
Reagan Tesoro, Notre Dame of Marbel University, Koronadal City, Philippines
75.4
Scientific Basic Study on Using Formicidae and White Ants in Prevention, Treatment of Diseases
Vo Tuong Kha, Vietnam Institute of Sport Science, Hanoi, Vietnam
75.5
High Throughput Screening of a Hyper-permeable Escherichia coli Mutant in Liquid and Solid Media
Xiaoming Li, University of Alberta, Edmonton, AB, Canada
75.6
Biochemical Characterization of Helicobacter pylori UDP-N-acetylmuramyl-L-alanine Ligase
Stephen Marmor, AstraZeneca R&D Boston, Waltham, MA, United States
75.7
Screening for Inhibitors of Hsp47, a Collagen-specific Chaperone
Helen Atkinson, McMaster University, Hamilton, ON, Canada
75.8
Inhibition of Plasmodium falciparum Proliferation In Vitro by Amide Analogues of Histone Deacetylase Inhibitor Trichostatin A
Wilai Noonpakdee, Mahidol University, Faculty of Science, Bangkok, Thailand
75.9
Purification and Properties of Polypeptide Nisin by Lactococcus lactis
Hanaa El-shafie, National Research Centre, Cairo, Egypt

76. Poster Session 24
Nanotechnology
76.1
An Alternative 3RS Method for Tetanus Immunoglobulin Measurment
Mojgan Taghizadeh Manzari, Food and Drug Control Labs, Tehran, Iran
76.2
Novel Modified Surface Biotechnologies Based on Functionalized Organosilane Self-assembled Monolayer on Oxidized Silicon Wafer
Johanne Moineau, The University of Tokushima, Tokushima, Japan
76.3
Electron Transfer in DNA Induced by Menadione: Modification of the Bridge Between the Acceptor and the Electron Donor
François Bergeron, Faculté de Médecine, Université de Sherbrooke, Sherbrooke, QC, Canada
76.4
Effects of Knot Structure on Enzymatic and Mechanical Properties of Bovine Carbonic Anhydrase II
M. Taufiq Alam, University of Rajshahi, Rajshahi, Bangladesh and Tokyo Institute of Technology, Yokohama, Japan

77. Poster Session 25
Technical Innovations—2D Gels and Other Gel Systems
77.1
Development of New Colloidal Stains: Narrowing the Gap Between Coomassie and Silver Staining Sensitivity
Gary Smejkal, Proteome Systems, Woburn, MA, United States
77.2
Withdrawn
77.3
Simplified and Improved 2-D Electrophoresis by Controlling Cysteine Oxidation
Jan Goscinski, Discovery Systems, Amersham Biosciences, Uppsala, Sweden
77.4
Analysis of Two Dimensional Gel Electrophoretic Separated Proteins After Imidazole-Zinc Staining
Heike Schaefer, Ruhr University Bochum, Bochum, Germany
77.5
Intact Protein Prefractionation Approaches for the Analysis of Complex Proteomic Samples
Scott Berger, Waters Corporation, Milford, MA, United States
77.6
Two Dimensional Offline HPLC/MS as a Tool to Elucidate Differences in Protein Expression Patterns from Patients with a Genetic Disorder and Their Healthy Relatives
Martin Vollmer, Agilent Technologies Deutschland GmbH, Waldbronn, Germany
77.7
Three-dimensional Fractionation of a Bacterial Proteome
Christian Wenz, Agilent Technologies, Waldbronn, Germany
77.8
Automation of Proteomics Workflow in Max-Planck-Institute Martinsried by Integrating Bruker Daltonics and Definiens Solutions
Ralph Humberg, Definiens AG, Munich, Germany
77.9
Gel Electrophoresis Enhancement: New Acrylamide Compounds for Hydrophobic Proteins Analysis
Caroline Tokarski, Université des Sciences et Technologies de Lille, Villeneuve D’Ascq, France
77.10
Cleanup/Concentration Techniques for the Identification of Low Abundant Proteins in 2D Gel Spots by MALDI Mass Spectrometry
David Heywood, Waters Corporation, ON, Canada

78. Poster Session 26
Organelle Proteomics
78.1
Integrative and Functional Proteomics of the Endoplasmic Reticulum
Eric Chevet, McGill University, Montréal, QC, Canada
78.2
Proteomic Approach in Determination of Phenobarbital Effects on Microsomal and Cytosolic Protein Expression Levels
Victor Zgoda, V. N. Orekhovich Institute of Biomedical Chemistry Rams, Moscow, Russia
78.3
Proteomic Database of the Lysosomal Membrane
Karine Landry, Sainte-Justine Hospital, Montréal, QC, Canada
78.4
Novel Proteins in the Endoplasmic Reticulum Uncovered by Proteomics Characterization of Isolated Rough and Smooth Microsomes
Annalyn Gilchrist, McGill University, Montréal, QC, Canada
78.5
The Soluble Proteome of Purified Mouse Endoplasmic Reticulum
Jody Groenendyk, University of Alberta, Edmonton, AB, Canada
78.6
Studying the Tissue Specificity of LMG160 Protein
Azadeh Razavi, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
78.7
Human Mitochondrial Protein Database
Veerasamy Ravichandran, National Institute of Standards and Technology, Gaithersburg, MD, United States
78.8
A Simple Method for Solution-based Global and Targeted Membrane Proteomics
Josip Blonder, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, National Cancer Institute at Frederick, Frederick, MD, United States
78.9
Proteomics of Rough and Smooth Endoplasmic Reticulum: 2-D Gel Results
Jacques Paiement, Université de Montréal, Montréal, QC, Canada
78.10
The ER Proteome: Focus on Rabs
Jennifer Gushue, Université de Montréal, Montréal, QC, Canada and Montréal Proteomics Network, Montréal, QC, Canada
78.11
A Novel Family of Endocytic Proteins Identified Through Subcellular Proteomics of Clathrin-coated Vesicles
Brigitte Ritter, McGill University, Montréal, QC, Canada
78.12
Purification of Cardiac Sarcoplasmic Reticulum Vesicles by Affinity Chromatography and Separation of the Ryanodine Receptor by SDS-Agarose Gel Electrophoresis
Geoffrey Hesketh, Johns Hopkins University, Baltimore, MD, United States
78.13
Analysis and Identification of Membrane Proteins Using a Non-discriminatory Investigative Approach
Daniel Gauthier, Montreal Clinical Research Institute, Montréal, QC, Canada
78.14
Proteomic Examination of Human Neutrophilic Phagosomes
Andrzej Jankowski, Ceraphyne Corp., Toronto, ON, Canada
78.15
Proteomics Characterization of Rat Liver Golgi Fractions and Golgi-derived COPI Coatomer Decorated Vesicles
Catherine Au, McGill University, Montréal, QC, Canada
78.16
Proteomics Characterization of Cardiac Muscle Cell Sarcolemma—Preliminary Analysis
Roxana Atanasiu, McGill University, Montréal, QC, Canada
78.17
Initiating Analysis of the Proteome of the Ciliated Protozoan Tetrahymena thermophila
Jeff Smith, York University, Toronto, ON, Canada
78.18
The Proteins of the Phagosome Prepared from IgG Opsonized Particles Engulfed by Raw Macrophages
John Marshall, Ryerson University, Toronto, Ontario, Canada
78.19
Influence of LC-Q-TOF Gradient Length on Discrimination of Homologous Proteins: Cytochrome P450 Family from Rat Liver Endoplasmic Reticulum
Souad Lesimple, Montréal Proteomics Center, Montréal, QC, Canada
78.20
When Small GTPases Meet with ATPases: Functional Significance of this "Rendez-vous" for Kidney Epithelial Cells
Vladimir Marshansky, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
78.21
Use of Complementary Mass Spectrometry Technologies for the Most Comprehensive Characterization of Proteins Found in the 46 to 57 kDa Region of the Rough Membrane Endoplasmic Reticulum Fraction (RM)
Daniel Boismenu, Montréal Proteomics Network, Montréal, QC, Canada
78.22
Proteomic Analysis of Endosomal Glycoproteins: Control of DPP IV Traffic by Insulin
Nicolas Bilodeau, Université Laval, Québec, QC, Canada
78.23
Cytochrome P450 Proteins Identified by Mass Spectrometry from Enriched Rough and Smooth Rat Hepatic Endoplasmic Reticulum
Alexander Bell, Montréal Proteomics Network, Montréal, QC, Canada

79. Poster Session 27
Medical Proteomics—Genetic Diseases
79.1
Friedreich’s Ataxia: An Autosomal Recessive Disorder of Triplet Repeat
Safia Khatri, The Aga Khan University, Karachi, Pakistan and University of Karachi, Karachi, Pakistan
79.2
A Haplotype of Five SNPs in GABAA Receptor B2 Gene Associated with Schizophrenia
Wing Sze Lo, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, P.R. China
79.3
The Diagnosis of Most Prevalant Mutations in Beta Globin Gene Surviving in East Azerbayjan of Iran
Mojtaba Mohaddes Ardebili, Tabriz Drug Applied Research Center, Tabriz, Iran
79.4
Characterization of the Lysosomal N-Acetyltransferase Involved in Sanfilippo C Syndrome by Combined Biochemical and Proteomic Approaches
Jerome Ausseil, Ste. Justine Hospital, University of Montréal, Montréal, QC, Canada

80. Poster Session 28
Proteomics & Biotechnology
80.1
Purification of Caveolae Microdomains from HACAT Keratinocytes Followed by Proteomic Analysis Allows the Characterization of New Markers of Human Epidermis Layers
Gilles Lemaitre, SGF/CEA, Evry, France; Evry University, Evry, France
80.2
Photoaptamer Microarrays for the Quantitation of Disease-relevant Proteins
Rachel Ostroff, Somalogic, Inc., Boulder, CO, United States
80.3
Versatile Protein Labeling Using the Universal Linkage System ULS
Frank Opdam, Kreatech Biotechnologies, Amsterdam, The Netherlands
80.4
Expression Studies of cry2A Pesticidal Protein Genes Under cry1Ac Promoter
Abdul Kareem Khan, The Aga Khan University Medical College, Karachi, Pakistan and National Center of Excellence in Molecular Biology, University of the Punjab, Lahore-Pakistan
80.5
Rapid Sample Preparation and Protein Analysis
Tanja Neumann, Agilent Technologies Deutschland GmbH, Waldbronn, Germany
80.6
Highly Multiplexed Two-site Immunometric Assays for Cytokine Quantitation Using a Three-dimensional Polyacrylamide-based Substrate
Martin Sommer, Perkin Elmer Life and Analytical Sciences, Boston, MA, United States
80.7
Stable Immobilization of His-tagged Proteins with Successive Ni2+-Nitrilotriacetic Acid-chelating and Amine-coupling
Yorimasa Suwa, Reverse Proteomics Research Institute Co., Ltd., Kisarazu, Chiba, Japan
80.8
1-Aminocyclopropane-1-carboxylate Deaminase, Plant Ethylene and Flower Fade
Stepanka B. Sebestianova, University of South Bohemia, Faculty of Biology, Ceske Budejovice, Czech Republic
80.9
Novel Foods—Safety Assessment: Evaluation of the Allergenicity of Carrots with Increase Lycopene Content In Vitro
Klaus-Dieter Jany, Federal Research Centre for Nutrition, Karlsruhe, Germany
80.10
Isolation and Cloning of Xylanase Beta-Glucosidase Genes from Trichoderma harzianum
Munir Ahmad Sheikh, University of Agriculture, Faisalabad, Pakistan
80.11
An Approach to Quantitative Profiling of the E. coli Proteome
Gudrun Franke, University of Bochum, Bochum, Germany
80.12
New Technologies Enabling the Elucidation of the Human Serum Proteome
H. Kelly Zhang, Agilent Technologies Inc., Wilmington, DE, United States
80.13
Global Antibody-assisted Differential Display of Proteome
Shu-cai (David) Huang, Genetel Laboratories LLC, Madison, WI, United States
80.14
The High Level Expression of C4 Phosphoenopyruvate Carboxylase and its Physiological Function in Transgenic Rice
Demao Jiao, Institute of Agrobiological Genetics and Physiology, Jiangsu Academy of Agricultural Sciences, Nanjing, China
80.15
Viral Proteomics: Structural and Functional Characterization of Potential Drug Discovery Targets
Mian Gao, Affinium Pharmaceuticals Inc., Toronto, ON, Canada
80.16
Designing Combinatorial Protein Libraries Based on a Protein Toxin Template
Subodini Perampalam, University of Toronto, Toronto, ON, Canada
80.17
Novel, Multi-sample Format for the Isolation of Mitochondria from Cultured Mammalian Cells
Betsy Benton, Pierce Biotechnology Inc., Milwaukee, WI, United States

81. Poster Session 29
Mitochondrial Biogenesis and Evolution
81.1
Mammalian Mitochondria 5'-End Oligonucleotide Microarrays and Application
Tao Chen, Cidmax Corporation, London, ON, Canada
81.2
Alteration of Mitochondrial Mass in Response to Enhanced Oxidative Stress in Human Cells
Cheng-Feng Lee, National Yang-Ming University, Taipei, Taiwan

82. Poster Session 30
Biological Energy Transduction
82.1
Mutagenesis Studies on Iron-Sulfur Cluster 3 of Escherichia coli
Victor Cheng, University of Alberta, Edmonton, AB, Canada
82.2
Effects of Site-directed Mutations on Heme Reduction in Escherichia coli Nitrate Reductase A (NarGHI) by Menaquinol: A Stopped-Flow Study
Zhongwei Zhao, University of Alberta, Edmonton, AB, Canada
82.3
Investigation of Novel E. coli Oxidoreductases Identified by Bioinformatic Analysis
Stephen Brokx, University of Alberta, Edmonton, AB, Canada
82.4
Is Stepping a Characteristic of all Rotary Molecular Devices?
Roy Caplan, Weizmann Institute of Science, Rehovot, Israel and McGill University, Montréal, QC, Canada
82.5
Cytosol-mitochondria Transfer of Reducing Equivalents by a Lactate Shuttle in Heterotrophic Euglena gracilis
Ricardo Jasso-Chávez, Instituto Nacional de Cardiología, México DF, Mexico
82.6
Structural Model of the F₁F₀ ATP Synthase Peripheral Stalk
Paul Del Rizzo, University of Western Ontario, London, ON, Canada
82.7
The Nitrate Respiratory Pathway: Structure and Energy Transduction Mechanism
Mika Jormakka, Imperial College London, London, United Kingdom

83. Poster Session 31
Cell Cycle Regulation
83.1
Identification of Phosphoproteome Components Altered During Thyroid Hormone-induced Metamorphosis of Frog Tadpoles
Dominik Domanski, University of Victoria, Victoria, BC, Canada
83.2
The Proteome of Pig Oocytes
Michal Kubelka, Institute of Animal Physiology and Genetics, Libechov, Czech Republic
83.3
State Specific Protein Phosphorylation Changes Induced by Inhibition of Cyclin-dependent Kinases
Hana Kovarova, Institute of Animal Physiology and Genetics, ASCR, Libechov, Czech Republic
83.4
Identification of Plasmodium falciparum Transcripts Differentially Expressed or Developmentally Regulated During the Sexual Cell Cycle
Germaine Tami Guemgne Simo, University of Nairobi, Nairobi, Kenya
83.5
On a Problem of Stress Hormone Adrenaline Mechanism Influence on Succinate System Cells of Mitochondrions
Tatiana Petrova, Russian Scientific Center of Recreational Medicine and Balneology, Moscow, Russia
83.6
Cdc48p-Septin Interaction During Cytokinesis Is Required for Actin Ring Assembly at the Bud Neck
Martin Latterich, McGill University, Montréal, QC, Canada
83.7
Apoptosis Induction and G1 Phase Arrest in Human Thyroid Cancer Cell Line Thr.CI.PI33 by 3-Hydrogenkwadaphnin Isolated from Dendrostellera lessertii
Azin Nowrouzi, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
83.8
Cell-free Expression of Src Kinase in Xenopus Oocyte and Egg Extracts
Alexander Tokmakov, Genomic Sciences Center, Yokohama Institute, Yokohama, Japan
83.9
Methylation of the Human PAX3 Upstream Region in Rhabdomyosarcomas
Raushan Kurmasheva, University of Arkansas for Medical Sciences, Little Rock, AR, United States
83.10
Critical Role of Hsp90 in Cell Cycle Control
Jinshan Wang, Institute of Basic Medical Sciences & Chinese Academy of Medical Sciences, Beijing, P.R. China
83.11
TGFbeta1-induced Growth Arrest Is Mediated by CIP/KIP Family Members in Follicular Lymphoma Cell Line
Daniel Tvrdik, Charles University in Prague, Prague, Czech Republic
83.12
Expression of Cell Cycle Proteins in the Evaluation of Hepatocyte Proliferation in Various Stages of Chronic Viral Hepatitis
Saira Sarfraz, The Aga Khan University and Hospital, Karachi, Pakistan
83.13
Cytostatic Effect of Protein Tyrosine Phophatase (PTP) Inhibition on Ovarian Cancer Cells
Danielle Caron, Laval University, Sainte-Foy, QC, Canada
83.14
MCL-1: A Possible Link Between Apoptosis and Cell Cycle Progression
Sarwat Jamil, University of British Columbia, Vancouver, BC, Canada
83.15
Dehydroepiandrosterone Induces Cell Cycle Arrest and Low Phosphorilate Form of Rb in Huvecs
Estrella Zapata, Instituto Nacional de Cardiología "Ignacio Chavez", México, Mexico and Universidad Autonoma Metropolitara, Iztapalapa, Mexico
83.16
Down Regulation of DHFR Promoter Activity by PML Transcription Repressor
Sadeq Vallian, Isfahan University, Isfahan, Iran

84. Poster Session 32
Metabolic Regulation and Metabolic Engineering
84.1
Manipulation of Phytosiderophore Biosynthesis and Release to Improve Zinc Efficiency in Wheat
Bhupinder Singh, Nuclear Research Laboratory, Indian Agriculture Research Institute, New Delhi, India
84.2
Glutamine Metabolism in the Clonal Pancreatic Beta Cell-line Brin BD11
Mary Corless, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
84.3
Pro-inflammatory Cytokine Induced Changes in Nutrient Metabolism and Insulin Secretion in a Clonal Pancreatic B-Cell Line
Aoife Kiely, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
84.4
Multiple Targets of 2,2', 5,5'-Tetrachlorobiphenyl on Oxidative Phosphorylation System in Liver Mitochondria
Rasa Baniene, Kaunas Medical University, Kaunas, Lithuania
84.5
Role of Phosphatidylinositide 3-Kinase in the Regulation of Homocysteine Metabolism
Shobhitha Ratnam, Memorial University, St John’s, NF, Canada
84.6
Homocysteine Metabolism in Type II Diabetes
Enoka Wijekoon, Memorial University of Newfoundland, St. John’s, NF, Canada
84.7
Mapping of the Active Site of Yeast Cystathionine Beta-synthase
Susan Aitken, Carleton University, Ottawa, ON, Canada
84.8
A Possible Link Between Genotype, Dietary Intake of Isothiocyanates and Incidence of Colorectal Cancer in an Ethnic Sub-population in New Zealand
Ellen Podivinsky, Institute of Environmental Science & Research Limited, Christchurch, New Zealand
84.9
Glutamine Administration Prevents Exercise-induced Apoptosis of Rat Neutrophils
Tania Pithon-Curi, Metodist University of Piracicaba and University Camilo Castelo Branco, São Paulo, Brazil
84.10
Comparative Effects of EPA and DHA on Proliferation, Cytokines Production and Pleiotropic Genes Expression in Jurkat Cells
Rui Curi, University of São Paulo, São Paulo, Brazil
84.11
Ubiquitous Distribution of Seminal Plasma Phospholipid-binding Proteins Suggests a Novel Role in Reverse Cholesterol Transport
Jasmine Lefebvre, Université de Montréal, Montréal, QC, Canada
84.12
Iron Regulatory Protein-1 Acts Not Only as a Metal Sensor Protein but as a Stress Sensor Protein
Satoru Oshiro, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-Ku, Tokyo, Japan
84.13
Methionine Metabolism: On the Mechanism of the Sparing Effect of Cysteine
Adam Byrne, Memorial University of Newfoundland, St. John’s, NF, Canada
84.14
Regulation of Proline Catabolism in Rat Liver
Mike Haslett, Memorial University of Newfoundland, St. John’s, NF, Canada
84.15
A Role of Gamma-Glutamylcysteine Synthetase in Propargylglycine Metabolism
Jun Ohta, Okayama University, Okayama, Japan
84.16
Sulfoconjugation of the 16-Androstene Steroids by the Leydig Cells of the Mature Domestic Boar
Philip Sinclair, University of Guelph, Guelph, ON, Canada
84.17
Endurance Exercise Increases Neuronal Nitric Oxide Synthase (nNOS) Expression in Equine Skeletal Muscle
Fernando José Peixoto, State University of Campinas, Campinas, SP, Brazil
84.18
Evidence for an Alternative Pathway for Cell Cholesterol Efflux
Yanie Porlier, Université de Montréal, Montréal, QC, Canada
84.19
Nitrosylation of Phenols: Mutagenic Activation of Soy Isoflavones In Vitro
Tim Schrader, Health Canada, Ottawa, ON, Canada
84.20
Analysis of the Rat Carnitine Palmitoyltransferase-I-alpha Promoter Using Transgenic Mice Carrying Promoter-Luciferase Transgenes
Eduard Lavrentyev, University of Tennessee Health Science Center, Memphis, TN, United States
84.21
Reactive Oxygen Species Production by Isolated Brain Mitochondria and Astrocytes
Armen Gyulkhandanyan, University of Toronto, Toronto, ON, Canada
84.22
Isotopic Kinetic Approach to the Metabolic Network Analysis
Alexander Shestov, The Catholic University of America, Washington, DC, United States
84.23
Leaf Nodulation: Two Metabolisms Entangled
Sandra Van Oevelen, University of Antwerp, Antwerp, Wilrijk, Belgium
84.24
Rat Intestinal Transport Enzymes: Effects of Consumption of Transgenic Papaya (Carica papaya L.)
Melissa Powell, University of the West Indies (Mona), Kingston, Jamaica
84.25
Glycemic Indices of Selected Food Crops of the Caribbean: Implications for the Management of Diabetes
Perceval Bahado-Singh, University of the West Indies (Mona), Kingston, Jamaica
84.26
Lipids and Lecithin: Cholesterol Acyltransferase (LCAT) Activity in Brazilian Schistosomiasis mansoni Patients Subjected to Auto-implantation of Spleen Tissue
Cesar A. de Silva, Federal University of Pernambuco, Recife/PE, Brazil
84.27
Effects of PPAR Agonists Via Receptor Dependent and Independent Mechanisms on Jurkat and Raji Cells
Rui Curi, University of São Paulo, São Paulo, Brazil
84.28
Macrophages Loaded with Arachidonic Acid Modulate Lymphocyte Proliferation
Rui Curi, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

85. Poster Session 33
Gene Structure, Function, and Regulation
85.1
The Application of Two DNA Vaccines Containing Glycoproteins D and B of Herpes Simplex Virus-1 for Protection of Mice Against the Wild Type Virus
Mohammad Hassan Roostaee, Tarbiat Modarres University, Tehran, Iran
85.2
The Effect of Hyperthermia on the Human Placental Growth Hormone Gene Expression
Solmaz Alizadeh Azami, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
85.3
The ICL1 Gene of Pichia Pastoris, Transcriptional Regulation and Use of its Promoter
Javier Menendez, University of Toronto, Toronto, ON, Canada
85.4
Functional Studies of the 900 Tetraloop-Receptor Interactions in 16S rRNA
François Bélanger, Université de Montréal, Montréal, QC, Canada
85.5
The Bacterial Ribosome Responds like the Eukaryote Ribosome to the Frameshift Stimulatory Signal of the Human Immunodeficiency Virus Type-1 (HIV-1)
Mélissa Léger, Université de Montréal, Montréal, QC, Canada
85.6
Loss of P300 Histone Acetyltransferase and Effect on Gene Expression in Butyrate-resistant HeLa Cells
John Th’ng, Northwestern Ontario Regional Cancer Centre, Thunder Bay, ON, Canada
85.7
Localization of Fibrillarin and its Role in Formation of Ribonucleoprotein Particles with Small Nuclear RNAs for Post Transcriptional Modification of rRNA in Giardia lamblia
Sandipan Ganguly, National Institute of Cholera and Enteric Diseases, Indian Council of Medical Research, Calcutta, West Bengal, India
85.8
The Effect of Microbial Hemoglobin in Acetoin and Butanediol Production
Suleyman Aydin, Firat University, Medical School, Elazig, Turkey
85.9
Special Expression of Foreign Gene Targeted fgfr4 in Mammary Gland of Transgenic Mice
Ji-Xian Deng, Beijing Institute of Biotechnology, Beijing, P.R. China
85.10
Functional Analysis and Genotype-Phenotype Correlation Study of VNTR Polymorphism in the Promoter Region of the Human Prostacyclin Synthase Gene
Dany Chevalier, Faculté de Médecine de Lille, Pôle Recherche, Lille, France
85.11
Conjugates of Oligo (2-O-Methylribonucleotides) with Minor Groove Binders as New Inhibitors of Transcription Elongation
Darya Novopashina, Novosibirsk Institute of Bioorganic Chemistry, Novosibirsk, Russia
85.12
Monitoring siRNA Transfection Efficiency and Gene Silencing Effect with a Microfluidic Chip Device
Tanja Neumann, Agilent Technologies Deutschland GmbH, Waldbronn, Germany
85.13
Analysis of Regulatory Pathways Underlying Differentiation in Malignant Glioma: The Roles of B-FABP and NFI
Jeffrey Coles, University of Alberta, Edmonton, AB, Canada
85.14
Bovine Kappa-Casein Gene (CSN3) Contains an Art2 Retroposon
Gilles Robitaille, Agriculture and Agrofood Canada, St-Hyacinthe, QC, Canada
85.15
Tomato Pal Genes: Highly Redundant but Strongly Underutilized
Ancheol Chang, University of Guelph, Guelph, ON, Canada
85.16
Locating Polyamine Cations Spermine, Spermidine, Putresine and Cobalt (III)-Hexamine in the Major and Minor Grooves of DNA Duplex
Amin Ahmed-Ouameur, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada
85.17
Analysis of the Gene for p26, a Small Heat Shock/ä,,-Crystallin Protein in Artemia franciscana
Zhijun Qiu, Dalhousie University, Halifax, NS, Canada
85.18
Transcriptional Regulation of a Hybrid Cluster (Prismane) Protein
Nina Filenko, University of Birmingham, Birmingham, United Kingdom
85.19
The Effect of p53 Status on Sensitivity to Anti-thymidylate Synthase Drugs in a Colon Cancer Cell Line
Seema Bissoon-Haqqani, University of Ottawa and Center for Cancer Therapeutics, Ottawa, ON, Canada
85.20
Binary Dnazymes and Hammerhead Ribozymes Targeted Cleavage MDR1 mRNA
Alesya Fokina, Novosibirsk Institute of Bioorganic Chemistry, Novosibirsk, Russia
85.21
Recruitment of Sp1, Sp3, HDAC1 and CK2 Phosphorylated HDAC2 and Dynamic Histone Acetylation of the Estrogen Regulated pS2 Promoter
Jim Davie, University of Manitoba, Winnipeg, MB, Canada
85.22
The Mouse Mix-like Gene, a Novel FoxH1 Target, Is Regulated by TGF-beta/Activin Signaling
Luisa Izzi, University of Toronto, Toronto, ON, Canada
85.23
A Supplementary Pathway of PKC in Heat Shock Response
Yu-fei Shen, Institute of Basic Medical Science, CAMS & PUMC, Beijing, P.R. China
85.24
The Role of Transcription Factor BTEB3 in the Regulation of Smooth Muscle-specific Gene Expression In Vivo
Mohammad Keramatipour, University of Cambridge, Cambridge, United Kingdom
85.25
Reconstruction of 48S Translational Initiation Complexes from Purified Components on Cap-dependent mRNAs with GC-rich 5'-UTRs: Increased Requirement to eIF4B and eIF2 Amounts
Sergey Dmitriev, Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia
85.26
Integrin Beta 7 Gene Regulation
Sushil Pandey, University of Auckland, Auckland, New Zealand
85.27
The Role of MAP Kinases in Regulating the Expression of the Leukocyte Integrin Beta7 Gene
Farhad Shafiei, University of Auckland, Auckland, New Zealand
85.28
Cloning, Expression and Characterization of Cel5B Gene from Thermotoga maritima Encoding a Novel Thermostable Endo-beta-mannanase
Attila Nemeth, Institute of Enzymology, Biological Research Center, Hungarian Academy of Science, Budapest, Hungary and Tokyo University of Pharmacy and Life Science, Tokyo, Japan
85.29
Genetic Polynorphism of Drug Metabolising Enzymes in African Populations
Collet Dandara, University of Cape Town, Cape Town, South Africa and University of Zimbabwe, Harare, Zimbabwe
85.30
Tree Domain Ribonucleases Are Present Only in Basidiomycetes
Norio Inokuchi, Nihon University, Funabasi, Chiba, Japan
85.31
Growth-rate-dependent RNA Polyadenylation in Escherichia coli
Jacek Jasiecki, University of Gdansk, Gdansk, Poland
85.32
FLOR1, a Putative Interaction Partner of the FLORAl Homeotic Protein Agamous, Is a Plant-specific Intracellular LRR
Alicia Gamboa, Instituto de Ecología, Universidad Nacional Autónoma de México, México, Mexico
85.33
Sequence and Structure Specific Radiation Damage in Bromodeoxyuridine Sensitized DNA
Sylvain Cecchini, Médecine Nucléaire et Radiobiologie, Université de Sherbrooke, Sherbrooke, QC, Canada
85.34
Toxin Diversity in the Neotropical Scorpion Genus Tityus (Buthidae) Revealed by Mass Spectrometry and cDNA Sequencing Analyses
Adolfo Borges, Institute Of Experimental Medicine-UCV, Caracas, Venezuela
85.35
Examination of Respiratory Competence in Yeast Strains Differentially Expressing the 21S Ribosomal RNA Methyl Transferase PET56p
Matthew Young, University of Manitoba, Winnipeg, MB, Canada
85.36
Inteins with Large Tandem Repeats Affecting Protein Splicing
Xiang-Qin Liu, Dalhousie University, Halifax, NS, Canada
85.37
Seven Introns and Inteins in a Bacterial Ribonucleotide Reductase
Xiang-Qin Liu, Dalhousie University, Halifax, NS, Canada
85.38
Elevated Expression of the hWAC Gene in Response to Long Term Marrow Culture (LTMC) Activation
Baiwei Gong, Institute of Medical Science, Toronto, ON, Canada
85.39
Functional Genomics of Leaf Senescence-Associated Genes in Rice
Shu-Chen Grace Chen, Academia Sinica, Nankang, Taipei, Taiwan
85.40
NMR Structural Studies on RTBP/DNA Complex
Weontae Lee, Yonsei University, Seoul, South Korea
85.41
Citrate Synthase from Thermoplasma volcanium and Construction of its Fusion Products
Caglar Cekic, Middle East Technical University, Ankara, Turkey
85.42
Functional Studies on Different Proteases of Thermoplasma volcanium
Caglar Cekic, Middle East Technical University, Ankara, Turkey
85.43
Trypanosoma cruzi Permeable Cells as a Model for Drug Activity Study
Regina Cicarelli, Faculdade de Ciências Farmacêuticas—Unesp, Araraquara, Brazil
85.44
Role of the CgtA Gene Function in DNA Replication of Extrachromosomal Elements in Escherichia coli
Agata Czyz, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Gdansk, Poland
85.45
PCR and Dot Blot Analysis of Transgenic Cotton Plants
Zahid Mahmood, University of Agriculture, Faisalabad, Pakistan
85.46
Identification of Schizont cDNAs Located on a Subtelomeric Fragment of the Theileria parva Genome
Kevin Raymond Oluoch, Lund University, Lund, Sweden
85.47
Gene Function Annotation: Predictive Data Mining Approach
Sivakumar Kannan, Université de Montréal, Montréal, QC, Canada
85.48
Evaluation of Human Choline Transporter CTL1 Gene: Structure, Splicing and Promoter Usage
Angela Tie Ten Quee, University of Guelph, Guelph, ON, Canada
85.49
Translational Regulation of Apolipoprotein B mRNA by Insulin Involves a trans-Acting Binding Protein Interacting with the 5' Untranslated Region
Konstantinos Gus Sidiropoulos, University of Toronto, Toronto, ON, Canada
85.50
Glucocorticoids Potentiate Preadipocyte Differentiation Through LBD-mediated Downregulation of an HDAC1-containing Complex
Julianna Tomlinson, Ottawa Health Research Institute, Ottawa, ON, Canada and University of Ottawa, Ottawa, ON, Canada
85.51
Functional and Physical Interactions Between STAT-1 and Ets Family Members in IFN-gamma Induced Signaling Pathway
Paule Cantin, Laval University Research Center, Québec, QC, Canada
85.52
Overexpression of a Newly Cloned and Characterized Gene, XRRA1, Demonstrates a Lack of Nuclear KU-86 Immunostaining
Felix Mesak, Ottawa Regional Cancer Centre, Ottawa, ON, Canada
85.53
Altered Expression of Phosphoenolpyruvate Carboxykinase in AtpG Mutants of the H+-transporting (F1F0) ATPase in Escherichia coli
Hughes Goldie, University of Saskatchewan, SK, Canada
85.54
The Effect of the Vitamin C on the Oxidatives Products of DNA
Johann Rivière, Université de Sherbrooke, Sherbrooke, QC, Canada
85.55
The Novel Genes, Fad24 and Fad158, Stimulate Adipogenesis
Masayoshi Imagawa, Nagoya City University, Grad. Sch. of Pharm. Sci., Nagoya, Japan
85.56
Enzymatic Repair of 2'-Deoxycytidine Glycols by Endonuclease III
Sébastien Tremblay, University of Sherbrooke, Sherbrooke, QC, Canada
85.57
The Selection of Molecular Markers for the Identification of Leaf Rust Resistant Genes
Gulnara Ismagulova, Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan
85.58
Polymorphisms of Mitochondrial DNA D-loop and V-region in Modern and Ancient Populations of Kazakh Territory
Naghima Aytkhozhina, Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan
85.59
Paraoxonase Gene Polymorphism in Position 54 Directly Typed by the Polymerase Chain Reaction
Elena Ludvikova, Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan
85.60
Protein Traffic on the Ribosome: Regulation of the GTPase Activity of Translation Factors
Andrei Zavialov, Uppsala University, Uppsala, Sweden
85.61
The Interactions Between the Regulatory Elements May Facilitate Enhancer-Promoter Interactions in the Abdominal-B Gene
Natalia Gruzdeva, In